Pretraga rezultata za izvrsnost 2025




IBI: AS134; Sonja Zafirović***, viši naučni saradnik, Univerzitet u Beogradu, Institut za nuklearne nauke 'Vinča'; Polje: prirodno-matematičke i medicinske nauke; Period: 2020-2024;


eNauka profil: rp03695; ORCID: 0000-0002-5486-0079;


WOS indikatori: NR = 40; TC = 1133; HIndex = 17;


eNauka WOS indikatori: NR = 42; TC = 1138; HIndex = 17 ;


Lista A broj bodova: 99.45188 (569) 33.0%; Lista B broj bodova: 761.2821 (569) 3.7%; Lista C broj bodova: 0.000 (0) nan%; Lista A broj bodova kolaboracije: 0.000 (0) nan%; Lista B broj bodova kolaboracije: 0.000 (0) nan%;

Statistika svih rezultata

StatistikaUkupno2013-20242015-20242018-20242020-2024
Broj rezultata4035322117
Broj citata1133899
Broj M bodova119.00119119.00119
Normirani broj citata959.02761.28
Normirani broj M bodova rezultata kategorije M21a++M21a+M21+M22+M23+M2499.4599.4599.4599.45
Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M410.000.000.000.00
Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41+M420.000.000.000.00
Normirani broj M bodova rezultata kategorije M510.000.000.000.00
Normirani broj M bodova rezultata kategorije M43+M440.000.000.000.00

Statistika rezultata nastalih u medunarodnim kolaboracijama

StatistikaUkupno2013-20242015-20242018-20242020-2024
Broj rezultata sa 20 i više autora00000
Broj citata rezultata sa 20 i više autora00
Broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora0.0000.000
Normirani broj citata rezultata sa 20 i više autora0.000.00
Normirani broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora0.000.00

Rezultati

RBIBIGodinaKatTipVrstaReferencaTCTCPBANBBNTCNaslovAutori
1.AS1342013EHORMONE AND METABOLIC RESEARCH Vol. 45 (10): # 701 - 708 (8), (DOI: 10.1055/s-0033-1343478) SEP 2013WOS24218017.5000Anti-atherogenic Effects of 17β-EstradiolResanovic I, Rizzo M, Zafirovic S, Bjelogrlic P, Perovic M, Savic K, Patti A, Isenovic R
2.AS1342014EMOLECULAR AND CELLULAR ENDOCRINOLOGY Vol. 388 (1-2): # 58 - 68 (11), (DOI: 10.1016/j.mce.2014.03.005) MAY 5 2014WOS252310014.3750In vivo effects of 17β-estradiol on cardiac Na+/K+-ATPase expression and activity in rat heartObradovic M, Stewart A, Pitt S, Labudovic-Borovic M, Sudar E, Petrovic V, Zafirovic S, Maravic-Stojkovic V, Vasic V, Isenovic E
3.AS1342014EJOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS Vol. 19 (3): # 256 - 268 (13), (DOI: 10.1177/1074248413513499) MAY 2014WOS44407040.0000Regulation of Endothelial Nitric Oxide Synthase and High-Density Lipoprotein Quality by Estradiol in Cardiovascular PathologyKypreos K, Zafirovic S, Petropoulou P, Bjelogrlic P, Resanovic I, Traish A, Isenovic E
4.AS1342015EMOLECULAR AND CELLULAR ENDOCRINOLOGY Vol. 416 (C): # 46 - 56 (11), (DOI: 10.1016/j.mce.2015.08.020) NOV 15 2015WOS15147014.0000Effects of 17β-estradiol on cardiac Na+/K+-ATPase in high fat diet fed ratsObradovic M, Zafirovic S, Jovanovic A, Milovanovic E, Mousa S, Labudovic-Borovic M, Isenovic E
5.AS1342015EINTERNATIONAL JOURNAL OF ENDOCRINOLOGY Vol. 2015 (): #147070 - (9), (DOI: 10.1155/2015/147070) 2015WOS20147014.0000Effects of Levothyroxine Replacement Therapy on Parameters of Metabolic Syndrome and Atherosclerosis in Hypothyroid Patients: A Prospective Pilot StudyGluvic Z, Sudar E, Tica J, Jovanovic A, Zafirovic S, Tomasevic R, Isenovic E
6.AS1342015EANGIOLOGY Vol. 66 (1): # 25 - 35 (11), (DOI: 10.1177/0003319713514477) JAN 2015WOS26256025.0000Estradiol In Vivo Induces Changes in Cardiomyocytes Size in Obese RatsObradovic M, Sudar E, Zafirovic S, Stanimirovic J, Labudovic-Borovic M, Isenovic E
7.AS1342015ECLINICAL LIPIDOLOGY Vol. 10 (2): # 167 - 175 (9), (DOI: 10.2217/CLP.15.8) 2015WOS14138010.8333Effects of altered hepatic lipid metabolism on regulation of hepatic iNOSStanimirovic J, Obradovic M, Zafirovic S, Resanovic I, Bogdanovic N, Gluvic Z, Mousa S, Isenovic E
8.AS1342015ELETTERS IN DRUG DESIGN & DISCOVERY Vol. 12 (2): # 158 - 164 (7), (DOI: ) 2015WOS33703.0000Non-Classical Therapeutic Approach in the Treatment of Alzheimer's Disease: A Mini ReviewBajic V, Spremo-Potparevic B, Zivkovic L, Sudar E, Zafirovic S, Obradovic M, Isenovic E
9.AS1342016ENITRIC OXIDE-BIOLOGY AND CHEMISTRY Vol. 54 (): # 51 - 59 (9), (DOI: 10.1016/j.niox.2016.02.007) APR 1 2016WOS32288023.3333A high fat diet induces sex-specific differences in hepatic lipid metabolism and nitrite/nitrate in ratsStanimirovic J, Obradovic M, Jovanovic A, Sudar-Milovanovic E, Zafirovic S, Pitt S, Stewart A, Isenovic E
10.AS1342016EMINI-REVIEWS IN MEDICINAL CHEMISTRY Vol. 16 (2): # 94 - 103 (10), (DOI: 10.2174/1389557515666151016125826) 2016WOS30248020.0000Benefits of L-Arginine on Cardiovascular SystemSudar-Milovanovic E, Obradovic M, Jovanovic A, Zaric B, Zafirovic S, Panic A, Radak D, Isenovic E
11.AS1342017EMOLECULAR AND CELLULAR ENDOCRINOLOGY Vol. 446 (C): # 12 - 20 (9), (DOI: 10.1016/j.mce.2017.02.001) MAY 5 2017WOS13128010.000017β-Estradiol protects against the effects of a high fat diet on cardiac glucose, lipid and nitric oxide metabolism in ratsZafirovic S, Obradovic M, Sudar-Milovanovic E, Jovanovic A, Stanimirovic J, Stewart A, Pitt S, Isenovic E
12.AS1342017ECURRENT PHARMACEUTICAL DESIGN Vol. 23 (10): # 1427 - 1434 (8), (DOI: 10.2174/1381612823666170124124855) 2017WOS12127012.0000Hormonal Regulation of Nitric Oxide (NO) in Cardio-metabolic DiseasesSudar-Milovanovic E, Zafirovic S, Jovanovic A, Trebaljevac J, Obradovic M, Cenic-Milosevic D, Isenovic E
13.AS1342017ECURRENT VASCULAR PHARMACOLOGY Vol. 15 (5): # 491 - 500 (10), (DOI: 10.2174/1570161114666161025101303) 2017WOS1513909.2857Influence of a High-fat Diet on Cardiac iNOS in Female RatsJovanovic A, Sudar-Milovanovic E, Obradovic M, Pitt S, Stewart A, Zafirovic S, Stanimirovic J, Radak D, Isenovic E
14.AS1342017ECURRENT VASCULAR PHARMACOLOGY Vol. 15 (2): # 115 - 122 (8), (DOI: 10.2174/1570161115666161104095522) 2017WOS38534180284.1667Apoptosis and Acute Brain Ischemia in Ischemic StrokeRadak D, Katsiki N, Resanovic I, Jovanovic A, Sudar-Milovanovic E, Zafirovic S, Mousa S, Isenovic E
15.AS1342018EJOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS Vol. 32 (6): # 1369 - 1377 (9), (DOI: ) NOV-DEC 2018WOS44704.000017β-ESTRADIOL INHIBITS HEPATIC iNOS VIA THE ACTIVATION OF THE ESTROGEN RECEPTOR ER-α AND INHIBITION OF ERK1/2-miR-221 AXISPanic A, Stanimirovic J, Obradovic M, Zafirovic S, Sudar-Milovanovic E, Petrovic N, Isenovic E
16.AS1342019EOXIDATIVE MEDICINE AND CELLULAR LONGEVITY Vol. 2019 (): #5028181 - (14), (DOI: 10.1155/2019/5028181) 2019WOS1211018084.1667Glutathione "Redox Homeostasis" and Its Relation to Cardiovascular DiseaseBajic V, Van N, Obradovic M, Zafirovic S, Radak D, Bajic V, Essack M, Isenovic E
17.AS1342019ECURRENT PHARMACEUTICAL DESIGN Vol. 25 (35): # 3715 - 3725 (11), (DOI: 10.2174/1381612825666191106091507) 2019WOS38297029.0000Effects of IGF-1 on the Cardiovascular SystemObradovic M, Zafirovic S, Soskic S, Stanimirovic J, Trpkovic A, Jevremovic D, Isenovic E
18.AS1342019ECURRENT VASCULAR PHARMACOLOGY Vol. 17 (3): # 307 - 318 (12), (DOI: 10.2174/1570161116666180212142414) 2019WOS54704.0000Involvement of PI3K, Akt and RhoA in Oestradiol Regulation of Cardiac iNOS ExpressionZafirovic S, Sudar-Milovanovic E, Obradovic M, Djordjevic J, Jasnic N, Borovic M, Isenovic E
19.AS1342020M21aEReviewBIOMEDICINE & PHARMACOTHERAPY Vol. 124 (): #109881 - (8), (DOI: 10.1016/j.biopha.2020.109881) APR 2020WOS262098.571414.2857Regulation of nitric oxide production in hypothyroidismGluvic Z, Obradovic M, Sudar-Milovanovic E, Zafirovic S, Radak D, Essack M, Bajic V, Gojobori T, Isenovic E
20.AS1342020M21EArticleOXIDATIVE MEDICINE AND CELLULAR LONGEVITY Vol. 2020 (): #5904315 - (13), (DOI: 10.1155/2020/5904315) MAR 28 2020WOS33124.00001.5000DES-ROD: Exploring Literature to Develop New Links between RNA Oxidation and Human DiseasesEssack M, Salhi A, Van N, Raies A, Tifratene F, Uludag M, Hungler A, Zaric B, Zafirovic S, Gojobori T, Isenovic E, Bajic V
21.AS1342020M21EReviewBIOFACTORS Vol. 46 (2): # 246 - 262 (17), (DOI: 10.1002/biof.1559) MAR 2020WOS1816105.000010.0000Redox control of vascular biologyObradovic M, Essack M, Zafirovic S, Sudar-Milovanovic E, Bajic V, Van N, Trpkovic A, Stanimirovic J, Bajic V, Isenovic E
22.AS1342020M21EReviewFRONTIERS IN GENETICS Vol. 10 (): #1368 - (11), (DOI: 10.3389/fgene.2019.01368) JAN 28 2020WOS262295.714315.7143The X Files: "The Mystery of X Chromosome Instability in Alzheimer's Disease"Bajic V, Essack M, Zivkovic L, Stewart A, Zafirovic S, Bajic V, Gojobori T, Isenovic E, Spremo-Potparevic B
23.AS1342020M22EArticleMEDICAL HYPOTHESES Vol. 134 (): #109419 - (5), (DOI: 10.1016/j.mehy.2019.109419) JAN 2020WOS1193.57140.7143Antioxidant enzymes expression in lymphocytes of patients undergoing carotid endarterectomyObradovic M, Zafirovic S, Essack M, Dimitrov J, Zivkovic L, Spremo-Potparevic B, Radak D, Bajic V, Isenovic E
24.AS1342022M21EReviewMEDIATORS OF INFLAMMATION Vol. 2022 (): #3706508 - (15), (DOI: 10.1155/2022/3706508) MAY 17 2022WOS1165395.714337.8571Role of C-Reactive Protein in Diabetic InflammationStanimirovic J, Radovanovic J, Banjac K, Obradovic M, Essack M, Zafirovic S, Gluvic Z, Gojobori T, Isenovic E
25.AS1342022M21EReviewCURRENT VASCULAR PHARMACOLOGY Vol. 20 (6): # 465 - 474 (10), (DOI: 10.2174/1570161120666220819164240) 2022WOS3278.00002.0000Association Between Telomere Length and Cardiovascular Risk: Pharmacological Treatments Affecting Telomeres and Telomerase ActivityZafirovic S, Macvanin M, Stanimirovic J, Obradovic M, Radovanovic J, Melih I, Isenovic E
26.AS1342022M22EReviewCURRENT PHARMACEUTICAL DESIGN Vol. 28 (25): # 2065 - 2072 (8), (DOI: 10.2174/1381612828666220620160516) 2022WOS261965.000019.0000Hypothyroidism and Risk of Cardiovascular DiseaseGluvic Z, Zafirovic S, Obradovic M, Sudar-Milovanovic E, Rizzo M, Isenovic E
27.AS1342023M21EArticleMEDICAL HYPOTHESES Vol. 174 (): #111049 - (6), (DOI: 10.1016/j.mehy.2023.111049) MAY 2023WOS0078.00000.0000Does oestradiol treatment alleviate obesity-induced oxidative stress in the male liver?Panic A, Sudar-Milovanovic E, Stanimirovic J, Obradovic M, Zafirovic S, Soskic S, Isenovic E
28.AS1342023M21EArticleFRONTIERS IN ENDOCRINOLOGY Vol. 14 (): #1241223 - (11), (DOI: 10.3389/fendo.2023.1241223) SEP 28 2023WOS1195.71430.7143Nitric oxide, thyroglobulin, and calcitonin: unraveling the nature of thyroid nodulesSamardzic V, Macvanin M, Zafirovic S, Obradovic M, Gluvic Z, Grubin J, Gao X, Essack M, Isenovic E
29.AS1342023M21EReviewCURRENT MEDICINAL CHEMISTRY Vol. 30 (17): # 1922 - 1944 (23), (DOI: 10.2174/0929867329666220801161536) 2023WOS312058.000020.0000The Role of miRNAs in Metabolic DiseasesMacvanin M, Obradovic M, Zafirovic S, Stanimirovic J, Isenovic E
30.AS1342023M21EReviewFRONTIERS IN ENDOCRINOLOGY Vol. 13 (): #1092837 - (19), (DOI: 10.3389/fendo.2022.1092837) JAN 4 2023WOS481768.000017.0000The protective role of nutritional antioxidants against oxidative stress in thyroid disordersMacvanin M, Gluvic Z, Zafirovic S, Gao X, Essack M, Isenovic E
31.AS1342023M22EArticleANTIVIRAL THERAPY Vol. 28 (5): #13596535231208831 - (7), (DOI: 10.1177/13596535231208831) OCT 2023WOS3275.00002.0000Subacute thyroiditis following COVID-19 vaccination: Case presentationTomic A, Zafirovic S, Gluvic Z, Samardzic V, Macvanin M, Radunovic M, Isenovic E
32.AS1342023M23EArticleACTA ENDOCRINOLOGICA-BUCHAREST Vol. 19 (3): # 380 - 385 (6), (DOI: 10.4183/aeb.2023.380) JUL-SEP 2023WOS0053.00000.0000A CASE REPORT OF HAND AND FOOT SKIN CHANGES RESEMBLING PTU-INDUCED VASCULITIS IN A YOUNG MALE WITH DIFFUSE TOXIC GOITRETomasovic M, Sinik M, Gluvic Z, Zafirovic S, Isenovic E
33.AS1342023M21EEditorial MaterialFRONTIERS IN ENDOCRINOLOGY Vol. 14 (): #1149857 - (3), (DOI: 10.3389/fendo.2023.1149857) FEB 6 2023WOS11401.0000Non-coding RNA in diabetes and cardiovascular diseasesMacvanin M, Zafirovic S, Obradovic M, Isenovic E
34.AS1342024M21aEArticleARCHIVES OF MEDICAL SCIENCE Vol. 20 (3): # 1011 - 1015 (5), (DOI: 10.5114/aoms/177618) 2024WOS10412.00000.0000Insulin-like growth factor-1 reduces cardiac autosis through decreasing AMPK/FOXO1 signaling and Na+/K+-ATPase-Beclin-1 interactionBanjac K, Obradovic M, Zafirovic S, Isenovic E
35.AS1342024M22EArticleMOLECULAR BIOLOGY REPORTS Vol. 51 (1): #517 - (12), (DOI: 10.1007/s11033-024-09451-3) DEC 2024WOS2184.16670.8333The involvement of Akt, mTOR, and S6K in the in vivo effect of IGF-1 on the regulation of rat cardiac Na+/K+-ATPaseBanjac K, Obradovic M, Zafirovic S, Essack M, Gluvic Z, Sunderic M, Nedic O, Isenovic E
36.AS1342025EPEPTIDES Vol. 190 (): #171418 - (11), (DOI: 10.1016/j.peptides.2025.171418) AUG 2025WOS10400.0000IGF-1 contributes to cardiovascular protection in obesity by upregulating Na plus /K plus -ATPase activity and modulating key signaling pathways in rats on a high-fat dietBanjac K, Obradovic M, Zafirovic S, Isenovic E
37.AS1342025EEXPERT REVIEW OF MOLECULAR DIAGNOSTICS Vol. 25 (9): # 521 - 524 (4), (DOI: 10.1080/14737159.2025.2555867) SEP 2 2025WOS00700.0000Progress in diabetes diagnostics and treatment monitoring: breakthroughs in molecular and clinical testingRadovanovic J, Gluvic Z, Pajcin A, Zafirovic S, Soskic S, Suri J, Isenovic E
38.AS1342025EEXPERT REVIEW OF MOLECULAR DIAGNOSTICS Vol. 25 (12): # 915 - 928 (14), (DOI: 10.1080/14737159.2025.2599225) DEC 2 2025WOS00700.0000Molecular insights into the gut-thyroid axis: microbiota-driven biomarkers and diagnostic applicationsGluvic Z, Zafirovic S, Sudar-Milovanovic E, Stanimirovic J, Soskic S, Jevremovic D, Isenovic E
39.AS1342025EBIOMOLECULES AND BIOMEDICINE Vol. 25 (3): # 693 - 700 (8), (DOI: 10.17305/bb.2024.11153) 2025WOS00800.0000Correlation between blood cell indices and adiponectin and leptin levels in COVID-19Manojlovic M, Ilincic B, Bojovic M, Kolarski I, Naglic D, Stokic E, Zafirovic S, Isenovic E
40.AS1342025EBIOMOLECULES AND BIOMEDICINE Vol. (): # - (32), (DOI: 10.17305/bb.2025.13145) 2025 OCT 23 2025WOS00700.0000Mitochondrial dysfunction, reactive oxygen species, and diabetes mellitus - A triangular relationship: A reviewManojlovic M, Zafirovic S, Naglic D, Stokic E, Rizzo M, Suri J, Isenovic E

27. 04. 2026.; 00:05:58; Trajanje procesiranja: 0.021 s


Legenda:

RB - redni broj rezultata
IBI - identifikacioni broj istraživača
Godina - godina u kojoj je rezultat publikovan (isključivo sa kompletnom paginacijom)
Kat - kategorija rezulata
Tip - tip rezultata (teorijski, simulacioni ili eksperimentalni)
Vrsta - vrsta rezultata
Referenca - referenca rezultata (bez autora i naslova rezultata) sa direktnim linkom na rezultat (ako ima DOI broj), sa linkom na zapis u eNauci ili WOS
TC - ukupan broj citata rezulata na dan 31. 1. 2026. godine
TCP - ukupan broj citata rezultata u periodu 2015-2024
BA - broj autora na rezultatu
NBB - normirani broj bodova rezultata
NTC - normirani broj citata rezultata u periodu 2015-2024
Naslov - naslov rezultata
Autori - spisak svih autora ili najviše prvih 30 autora


Primer:

Primer normiranja broja M poena i broja citata ostvarenih na jednom rezultatu: eksperimentalni rad sa 11 autora u časopisu kategorije M21a+ koji je publikovan 2020. godine, citiran je 65 puta, od čega 55 puta u periodu 2015-2024. godine.

Normirani broj M poena koje istraživač ostvaruje na rezultatu je 20/(1+0.2*(11-10))=16.6667 a normirani broj citata je 55/(1+0.2*(11-10))=45.8333.

Ukupan broj ostaverinih bodova utvrđuje se na naznačenom periodu za sabiranje normiranih M poena svakog istraživača i u periodu za određivanje ukupnog broja normiranih citata (2015-2024).